Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The adolescent (and their caregiver, if applicable) must sign and date a consent form agreeing to take part
- For young people under 18, both the young person's agreement and a parent or guardian's signed permission are required
- Participants must be willing to follow all study steps and be available for the full length of the study
- The adolescent must be between 12 and 18 years old; caregivers of any age may also participate
- The adolescent must have a confirmed diagnosis of sickle cell disease (any type)
- The adolescent must score at least 3 on a standard pain screening tool used for young people (confirm with trial site)
- The adolescent must rate their typical pain over the past week as at least 4 out of 10 on a pain scale
- If the adolescent is taking any sickle cell medications (such as hydroxyurea or similar treatments), the dose must have been stable for at least the past 3 months
- Both the adolescent and caregiver must be able to speak and read English
Who may not be able to join:
- The adolescent has another medical condition not related to sickle cell disease that also causes pain (such as certain joint or bowel conditions)
- The adolescent has previously had gene therapy or a stem cell transplant
- The adolescent has any physical or mental health condition that would prevent safe participation in the study (confirm with trial site)
- The adolescent is currently receiving regular non-medication pain treatment (such as structured therapy sessions, physical therapy, or acupuncture) that would overlap with this study's active period
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Soumitri Sil, PhD, ABPP, Emory University
Phone: 404-727-2712
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Brief Pain Inventory (BPI) Pain severity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.